Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation Close
Home
  • Company
    • About
    • Quality
    • Careers
  • Platforms
    • BioJet Oral Therapeutic Delivery
    • NaviCap Targeted Therapeutic Delivery
  • Publications
  • News
    • Press Releases
    • Investor FAQs
  • Contact
Toggle the search bar
Close the mobile navigation

Publications

Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJetâ„¢ oral biotherapeutic delivery platform in a porcine model: an update
October 4, 2023 #BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJetâ„¢ oral biotherapeutic delivery platform in a porcine model
June 23, 2023 #BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
October 23, 2022 #BioJet Oral Therapeutic Delivery
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
October 23, 2022 #BioJet Oral Therapeutic Delivery
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
October 18, 2022 #BioJet Oral Therapeutic Delivery

Connect with us

Email Us Biora Therapeutics Linkedin Biora Therapeutics Twitter
  • Company

    About Quality Careers

    Platforms

    BioJet Oral Therapeutic Delivery NaviCap Targeted Therapeutic Delivery
  • Publications

    BioJet Publications NaviCap Publications
  • Connect with Us

    Contact Us
    Email Us Biora Therapeutics Linkedin Biora Therapeutics Twitter
Privacy & Terms of Use Accessibility

© 2025 Biora Therapeutics, Inc. All rights reserved. Biora Therapeutics, NaviCap, BioJet, and GITrac are trademarks of Biora Therapeutics, Inc.

Precaution: investigational drug/device combination products. Currently limited by Federal law to investigational use only. Not for sale in the U.S.